|
C14ORF109 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.755300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.323000E-03 |
| Normal-vs-Stage2 |
1.330580E-01 |
| Normal-vs-Stage3 |
2.906200E-01 |
| Normal-vs-Stage4 |
5.021900E-02 |
| Stage1-vs-Stage2 |
5.129200E-01 |
| Stage1-vs-Stage3 |
9.451000E-01 |
| Stage1-vs-Stage4 |
7.101000E-01 |
| Stage2-vs-Stage3 |
8.110000E-01 |
| Stage2-vs-Stage4 |
4.858400E-01 |
| Stage3-vs-Stage4 |
7.932400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.368700E-04 |
| Normal-vs-AfricanAmerican |
8.023900E-02 |
| Normal-vs-Asian |
7.379000E-01 |
| Caucasian-vs-AfricanAmerican |
2.139600E-01 |
| Caucasian-vs-Asian |
6.217600E-01 |
| AfricanAmerican-vs-Asian |
7.505000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.937000E-03 |
| Normal-vs-Female |
7.977900E-03 |
| Male-vs-Female |
5.664600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.014200E-04 |
| Normal-vs-Extreme_Weight |
7.461400E-03 |
| Normal-vs-Obese |
9.597800E-02 |
| Normal-vs-Extreme_Obese |
5.902200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.478800E-01 |
| Normal_Weight-vs-Obese |
2.405000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.413600E-01 |
| Extreme_Weight-vs-Obese |
6.882600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.734000E-01 |
| Obese-vs-Extreme_Obese |
7.518200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.142400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.110400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.340230E-03 |
| Normal-vs-Age(81-100Yrs) |
1.563960E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.005600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.354000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.092400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.668600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.958770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.079800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.196170E-02 |
| Normal-VS-Type2 PRCC |
1.350490E-02 |
| Normal-VS-KIRP CIMP |
7.901000E-01 |
| Normal-VS-Unclassified PRCC |
2.239000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.755600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.870800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.605830E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.919200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.476600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.473200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.341840E-01 |
| Normal-vs-N1 |
5.179900E-02 |
| Normal-vs-N2 |
3.599000E-04 |
| N0-vs-N1 |
7.072200E-01 |
| N0-vs-N2 |
1.737380E-01 |
| N1-vs-N2 |
1.036420E-01 |
|
|
